Declaration of interest
Emily Brown’s and Alastair Hay’s employer (the University of Bristol) has purchased the bioMereiux bioFire for the RAPID-TEST RCT (Award ID: NIHR131758, https://fundingawards.nihr.ac.uk/award/NIHR131758) under a standard procurement arrangement. They are not not receiving any direct or indirect financial or non-financial support from bioMereiux. Emily Brown is an NIHR Clinical Research Fellow (In Practice Fellowship). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Reviewers Disclosure
Peer reviewers on this manuscript have no relevant financial relationships or otherwise to disclose.